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ABSTRACT 
Fc receptors (FcR) a re immunoglobulin binding 
s tructures reacting with the Fc par t of the antibody 
molecules. These receptors are known to be par t i cu la r ly 
important for the function of var ious effector cells , such 
as macrophages, since they are involved in mediating a 
var ie ty of act ivi t ies including endocytosis, antibody-
dependent cel lular cytotoxicity, and t r igger ing the release 
of potent inflammatory agen ts . 
In this s tudy, goat per ipheral blood 
lymphocyte receptor, both from the cell homogenate as 
well as from isolated membrane, was isolated using 
affinity chromatography on heat aggregated goat 
IgG-Sepharose AB column. Goat IgG was isolated by 
ammonium sulphate precipi tat ion followed by ion exchange 
on diethylaminoethyl cellulose (equil ibrated with 0.01 M 
sodium phosphate buffer pH 8.0) and gel chromatography 
on Sephadex G-200 (equi l ibrated with 0.01 M sodium 
phosphate buffer pH 8.0, containing 0.15 M NaCl). Two 
peaks were obtained on Sephadex G-200 column. One peak 
eluting at the void volume contained aggregated IgG, 
other major peak containing monomeric IgG eluted at the 
Ve/Vo ratio of 1.^(3. IgG isolated by ion exchange 
i i i 
chromatography was used as such for heat aggregat ion. 
Protein solution (5-10 mg/ml) in 0.15 M NaCl was heated 
at 63"C for ten minutes. The turbid solution thus 
obtained was applied on Sephadex G-200 column 
(equil ibrated with 0.01 M sodium phosphate buffer pH 8.0, 
containing 0.15 M NaCl). Fractions under the void 
volume peak, containing aggregates were collected and 
pooled. For the preparat ion of affinity column, heat 
aggregated IgG was coupled to Sepharose 4B which was 
activated by cyanogen bromide. 
Lymphocytes were isolated from freshly 
obtained goat blood by density gradient centrifugation on 
Histopaque-1077. Lymphocytes as such, or their isolated 
membrane fractions, were used for the isolation of IgG 
binding protein. Lymphocyte membrane was prepared by 
hypotonic lysis of cells in 10 mM Tris-HCl buffer pH 7.0, 
containing 1 mM MgCl and 1 mM KCl at low temperature 
followed by centr ifugation. Lymphocytes or the 
membranes were solubilized in phosphate buffered saline 
pH 7.4, containing 0.5% NP-40, 2 mM PMSF and 3 mM 
EDTA, and the supernatant was incubated overnight with 
aggregated IgG-Sepharose 4B. After washing extensively 
with PBS, the bound protein was eluted with 0.5 M acetic 
acid containing 0.1% NP-40. 
i v 
The presence of IgG binding protein on goat 
per ipheral blood lymphocytes was detected by the specific 
binding of FITC-conjugated heat aggregated IgG to 
lymphocytes in 10 mM sodium phosphate buffer pH 7.4, 
containing 0.15 M NaCl, 1% BSA and 0.2% NaN^. The 
binding of FITC-conjugated heat aggregated IgG to goat 
lymphocytes increased with increase in the concentration 
of aggregated IgG fom 2 to 9 pg . Saturation in binding 
sites of 5x10 cells could be achieved with 0.191 pg/ml of 
aggregated IgG. 
The binding of IgG to lymphocytes was studied 
under different conditions of pH in the pH range 6-9 
which was maintained ei ther by 0.01 M sodium phosphate 
buffer (pH 6-8) or by 0.01 M sodium carbonate buffer 
(pH 9.0) . Maximum binding of aggregated IgG took place 
at pH 7.0 above which the change in pH caused 
considerable reduction in b inding . The effect of ionic 
strength on the binding of IgG to goat lymphocytes was 
studied in 10 mM phosphate buffer pH 7.4 at 8°C. 
Increasing concentration of NaCl upto 0.8 M caused 
significant decrease in b ind ing . 
ACKNOULEVGEUENTS 
The. dzpth o^ my 6e.n6t o^ g^jCuUXudz, the. magruXad^ o^ my fie^pecX-
ija£ne44 and the iinceAAXy o^ my tnteAxiat ^eeZying^ toiMAdb the gfieaX 
?fio{^e^6ofL in him oAz bzyond zxpAe^^ion. FO/L the. tcu>t two yeoAA, 
VK. A, SaZAhuddin, my neveAed giUdt, ha^ bee.n a constant ^ouAce of^ ini-
pinxition and encovJiagement {^ofi me and 6eAvz& 04 my model. 
Uy 6-inceAe thanlu afie due to PA.o£e^4,oK Raihid ALL, ChaiAman, 
VepoAXment 0($ BiochemAtAy, JMUC, ^oA providing me an oppoKtuYiLty to 
vdOAk In the. dzpanXment. 
I acknouitedge the ef^^^oAti and guidance 0(J VA. M.A. SiddLqui 
and VA. UaiiAooA Atom Baig who gAoome.d me to andeAXake. the. pAe^ent 
eiiofU. 
Thanks o^e. dut to VA. Saad Tayab and VA. Ja\jaid Ha^ioAot {^oA 
theiA kind help. 
I cannot ioAget to KecoAd a special thanlu tot my ex-ienioA 
colleague, MA.. KAi6hnan Hajela ^OA hii invaluable ai&idtance., pAo^ound 
coilaboAotion, &inceAe and unf^atiguable z(^{^0At^ indiipen&ible. to me 
in the. compilation o(^ thijt the^it,. 
I am alio much thank{^ul to my otheA &enioA colleagues McA4 ?aAve.en 
Salahaddin, ilCc44 hiajma ALL, ^^ /LA. Rena Tyagi, UAi. Sadhna ShoAina and 
UAi. Seema Hai-i>an ^OA thein. coopeAation. 
v i 
It mil not be oat 0|$ ptace to ^.xpKUi my appfiztiation {^ofi 
my coUiQAQUu and ^fUendi z^pzcMxlly iklLi> Kzm. kbJiji, Ma4 Hatima leJba., 
Aic4-4 Shcma. S^ddiquyL, Mci4 Sun^Xa (UcuuvcUch, Un.. A^tab Ahmad, M .^ ZLzwan 
Marian and M .^ Shaf^at QadfLt, who weAe ait too uUJUXng to hdtp me Xn 
my kouKit ojj need, 
Appfizciatxanii oAZ al&o due to tht membeA^ 0($ ^he non-t^acbing 
•ita^ {^ofL tkeJji tzchnical a44^-tance. 
I do not havz a m<iXaphofi ojj woA.d6 ^o exp^e^A my XKidebtediaeiA 
to my d<iaK {^fUand, M 4^4 Jahan AAA, ^oA the. 62Z^lz&.6 help txtundad by 
hoJi tn 4>otvtng mt/ pn.obiem6 at \}aju.oiu itagzi duAxng the. peAA^od ol 
tivU) i,tady. 
Lastly, I am thank{^uZ to hin.. Wamiq Ati ^OA exceZie.nt typing 
(^fLom badly mJJXzn mamii,cju.pt^. 
( IQSA GALZIE ) 
V l l 
Dedicated 
to 
Mq Paiients 
iOhosQ lOlsbes and encoaftagement 
enabled me to Iceach this stage 
CONTENTS 
ABSTRACT 
ACKNOWLEDGEMENTS 
DEDICATION 
LIST OF ABBREVIATIONS 
LIST OF TABLES 
LIST OF FIGURES 
I . INTRODUCTION 
I I . EXPERIMENTAL 
A. M a t e r i a l s 
B . M e t h o d s 
1 . P r e p a r a t i o n of s o l u t i o n s 
2 . pH m e a s u r e m e n t s 
3 . O p t i c a l m e a s u r e m e n t s 
4 . P r o t e i n e s t i m a t i o n 
5 . I o n e x c h a n g e c h r o m a t o g r a p h y 
6 . Gel f i l t r a t i o n 
7 . I s o l a t i o n of IgG a n d p r e p a r a t i o n of i t s 
d e r i v a t i v e s 
8 . I s o l a t i o n of l y m p h o c y t e s from g o a t b l o o d 
9 . I s o l a t i o n of l y m p h o c y t e m e m b r a n e 
PAGE 
11 
V 
v i i 
X 
x i i 
x i i i 
2 
37 
37 
38 
38 
40 
40 
40 
43 
46 
48 
54 
55 
i x 
10 . P r e p a r a t i o n of a f f i n i t y m e d i a . . 55 
1 1 . I s o l a t i o n of IgG b i n d i n g p r o t e i n . . 57 
12 . D e t e c t i o n of I g b i n d i n g p r o t i e n on g o a t 
l y m p h o c y t e s b y t h e b i n d i n g of F I T C -
c o n j u g a t e d IgG . . 53 
1 3 . I n t e r a c t i o n of c e l l s u r f a c e IgG b i n d i n g p r o t e i n 
w i t h F I T C - c o n j u g a t e d h e a t a g g r e g a t e d IgG . . 61 
( a ) Effect of i o n i c s t r e n g t h . . 63 
( b ) Effect of pH . . 63 
I I I . RESULTS AND DISCUSSION . . 64 
1 . I s o l a t i o n of IgG b i n d i n g p r o t i e n from g o a t 
l y m p h o c y t e s . . . 54 
( a ) I s o l a t i o n from w h o l e c e l l s . . 65 
( b ) I s o l a t i o n from m e m b r a n e . . 68 
2 . D e t e c t i o n of IgG b i n d i n g p r o t e i n on l y m p h o c y t e 
s u r f a c e . . 70 
3 . B i n d i n g of i m m u n o g l o b u l i n to i n t a c t l y m p h o c y t e s . . 73 
( a ) Effect of i o n i c s t r e n g t h '^ • • 73 
( b ) Effect of pH . . 75 
BIBLIOGRAPHY . . 79 
BIOGRAPHY . . 86 
LIST OF PUBLICATIONS/PRESENTATIONS . . 87 
LIST OF ABBREVIATIONS 
ADCC 
Agg FITC-IgG 
BSA 
cDNA 
DEAE 
EDTA 
Fab 
F ( a b ' ) 2 
FITC 
Fc 
FcR 
Fc^R 
0 
GPBL 
ig 
igA 
IgD 
IgE 
IgG 
IgGl 
TqG2 
IgG2a 
Antibody dependent cell mediated cytotoxicity 
Aggregated FITC-IgG 
Bovine serum albumin 
Complementary deoxyribonucleic acid 
Diethyl amlnoethyl 
Ethylene diamine te t ra acetic acid 
Fragment antigen binding 
Fragment antigen binding divalent 
Fluorescein isothiocyanate 
Fragment c rys ta l l izab le 
Receptor for Fc region of immunoglobulin 
Receptor for Fc regioi^ of IgG 
Goat per iphera l blood lymphocyte 
Immunoglobulin 
Immunoglobulin A . 
Immunoglobulin D 
Immunoglobulin E 
Immunoglobulin G 
Immunoglobulin subclass in human 
Immunoglobulin subclass in human 
Immunoglobulin subclass in mouse 
x i 
IgG2b Immunoglobul in s u b c l a s s in mouse 
IgM Immunoglobul in M 
IgG-BF Immunoglobul in G b i n d i n g factor 
mRNA Messenger r i b o n u c l e i c ac id 
NP-40 Nonidet P-40 
PBS Sodium p h o s p h a t e buffered s a l i n e 
PMSF Pheny l methyl s u l p h o n y l f luor ide 
TCA Tr i cho lo roace t i c ac id 
T r i s T r i s ( h y d r o x y methyl ) amino methane 
LIST OF TABLES 
TABLE PAGE 
I The family" of Fc receptors . . 5 
I I Sequence homology between mouse 
and human Fc receptor by domain . . 32 
I I I Isolation and purification of heat 
aggregated IgG from goat plasma . . 51 
LIST OF FIGURES 
FIGURE PAGE 
1. Structure of the mouse macrophage-
lymphocyte IgGl/IgG2b Fc receptor 
(mFcRII) •• 12 
2. Structure of three dist inct murine 
receptors deduced from cDNA's . . 15 
3. Pathways of Fc receptor-mediated 
endocytosis in mouse macrophages • • 24 
'*• Schematic representat ion of t r i pa r t i t e 
inact ivat ion model • • 28 
5. Calibration curve for the estimation 
of protein concentration by the 
method of Lowry et a l . (1951) . . 42 
6. Calibration curve for the estimation 
of protein concentration by the 
method of Cabib and Polacheck (1984) . . 44 
7. Calibration curve for the estimation 
of protein concentration by dye 
binding method (Bradford, 1976) . . 45 
8. Elution profile of 40% ammonium 
sulphate fraction of goat plasma on 
DEAE-cellulose column . , 49 
9. Elution profile of protein isolated 
after ion exchange chromatography 
on Sephadex G-200 column . . 50 
10. Elution profile of heat aggregated 
IgG on Sephadex G-200 column . . 53 
11. Calibration curve for the estimation 
of FITC-conjugated IgG . . 62 
x i v 
12. Affinity chromatography of protein 
solubilized from whole cells by 
NP-40 on aggregated IgG-Sepharose . . 66 
AD gel 
13. Rebinding of IgG binding protein 
isolated by affinity chromatography 
to aggregated IgG-Sepharose 4B gel . . 67 
14. Affinity chromatography of NP-40 
solubilized lymphocyte membrane on 
aggregated IgG-Sepharose 4B gel . . 69 
15. Detection of IgG binding protein on 
the surface of goat per iphera l blood 
lymphocytes by specific binding of 
fluorescein conjugated heat 
aggregated goat IgG . . 71 
16. Effect of ionic s trength on the 
interaction of IgG binding proteins 
on lymphocytes surface with 
immunoglobulins . . 74 
17. Effect of pH on fluorescence 
intensity of FITC-conjugated IgG(A) 
and i t s interact ion with IgGfbinding 
proteins on lymphocyte surface(B) . . 76 
studies on Fc RQC<2pto)i t^om Lqmphocqtes 
I.INTRODUCTION 
For the immune system to achieve i ts goal of 
protection of the organism agains t foreign ant igens , 
cooperation between the humoral and cel lular pathways 
occurs with the interact ion of ant ibody-ant igen complexes 
with effector cel ls , mediated by specific antibody receptors , 
Fc receptors (FcR) (Gergley, 1988; Hogg, 1988). A wide 
range of cells express FcR's , most of them belonging to the 
cell? of the immune system, iincluding monocytes, 
macrophages, granulocytes , K cel ls , B cells and some 
T cells; but FcR' s are present on membranes of other cell 
types as well. The FcR's expressed on cells of the 
immune system play important roles in immunological 
processes, such as phagocytosis of opsonized par t i c les , 
clearance of immune complexes, antibody dependent ce l lu lar 
cytotoxicity (ADCC), regulat ion of immune response, and 
mediation of s ignals for the production of inflammatory 
mediators. 
FcR's are s t ruc tu ra l ly and functionally very 
heterogeneous. Their heterogeneity manifests itself in 
binding of different isotypes of Igs (unkeless et a l . , 
1981), as well as in the mediation of var ious functional 
ac t iv i t ies . Macrophage-lymphocyte-epithelial cell FcR's 
are now knov/n to belong to one of the two la rge families, 
the first being a der iva t ive of an ances t ra l immunoglobu-
l in- l ike gene and the second being closely related to 
cel lular lectins (lymphocyte IgE receptors) . Moreover, the 
s t ruc tura l heterogeneity also appears to extend to within 
individual classes of FcR specific for single immunoglobu-
lin isotypes. Due t o . the heterogeneity of FcR's themselves 
and moreover to the difficulties in isolation and 
purification of the receptors to homogeneity, most of the 
biochemical studies on FcR s t ructure have resulted in 
conflicting re su l t s . 
Distribution of Fc receptors : 
•f FcR's have a wide dis t r ibut ion in na ture and a 
survey of the receptors described to date is compiled in 
Table I . Receptors have been identified as being 
membrane - associated or secreted by a la rge number of 
mammalian cell types . These include receptors for IgA, 
IgM, IgD, IgE, and var ious subclasses of IgG found on 
cells of the immune system (mononuclear cel ls , 
granulocytes , D cel ls , some T cells , NK cells) and 
various t ranspor t ing epi thel ia ( mammary ce l l s , 
hepatocytes, in tes t ina l epi thel ia in new born rodents ) . 
Certain FcR-negative cel ls , such as f ibroblasts , can be 
induced to express FcR following infection with certain DNA 
viruses ( Epstein-Barr v i rus , cytomegalovirus, herpes 
simplex v i rus ( H5V ) types 1 and 2 ) . Various s t ra ins 
of Staphylococci and Streptococci a re also known to express 
well characterized FcR act ivi t ies ( protein A, protein G ) . 
Fc receptors for IgG on murine macrophages and 
lymphocytes : 
In the mouse, three biochemically dist inct 
receptors for different IgG subclasses have been identified 
( Unkeless et a l . , 1981 ) { See Table I ) . 
(a) mFcRI : binds murine IgG2a and human IgGl with 
high avidity but can also bind aggregated immunoglobulin 
( Unkeless, 1977; Mellman and Unkeless, 1980 ); it is 
found only on macrophages ( Unkeless and Eisen, 1975 ); 
and is somewhat t ryps in sensit ive ( Unkeless, 1977 ). 
The IgG2a receptor is capable of mediating the 
phagocytosis of opsonized par t i c les . However, a 
monoclonal antibody to murine FcRI has yet to be produced and 
the polypeptide(s) responsible for receptor activi ty has not 
been definitively identif ied. 
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(b) mFcRII : specific for immune complexes or aggregates 
of murine IgGl and IgG2b ( Diamond and Scharff, 1980; 
Unkeless, 1979 ); has a low affinity for monomeric IgG; 
and is re la t ively res i s tan t to inact ivat ion by t ryps in . 
The IgGl/IgG2b FcR is widely distr ibuted on cells 
of the immune system, being found on macrophages, 
lymphocytes and granulocytes . They are most abundant on 
macrophages and lymphocytes being expressed in amounts 
of upto 2-6 X 10 per cell ( Mellman and Unkeless, 1980; 
Mellman et a l . , 1983; Mellman et a l . , 1984 ) . It is by 
far the best character ized receptor and i t s study has been 
facil i tated by the isolation of a ra t monoclonal antibody 
2.4G2, a 60K membrane glycoprotein directed agains t an 
epitope present on murine FcR' s of both macrophages and 
lymphocytes ( Unkeless, 1979; Mellman and Unkeless, 1980 ) 
However, immunoprecipitation using 2.4G2 from these diverse 
cell types has indicated the existence of considerable 
molecular v;oight heterogeneity on SDS-polyacrylamide gels 
(Mel lman and Unkeless, 1980 ) . 
(c) mFcRIII : specific for IgG3; s t ructure remains 
unidentified; and is character ized only as a t ryps in -
res is tant molecule capable of mediating the phagocytosis of 
IgG3-sensitized par t ic les ( Diamond §nd Yelton, 1981 ) . 
11 
s t ruc ture of the murine FcR: 
The application of monoclonal antibodies with 
anti-FcR specificity (Mellman et a l . , 1983; Green et a l . , 
1985) and cloning of FcR genes (Ravetch et a l . , 1986; 
Lewis et a l . , 1986; Hibbs et a l . , 1986) led to the real 
breakthrough in the s t ruc tura l ana lys is of FcR's . The 
predicted structure of FcR based oij, these resul ts may 
account for the differences in isotype specificity between 
macrophages and lymphocytes and characterize the basis 
for their functional heterogeneity. 
The receptor is another member of the immunoglo-
bulin gene super family, with closest homology to class I I 
histocompatibili ty an t igens . Following a leader sequence, 
there is an ex t race l lu la r portion tha t consists of two 
repeated immunoglobulin-like domains (Fig. 1) . Each 
domain, of approximately 85 amino acids has two sites for 
N-linked oligosaccharide and two cysteine residues which 
are separated by 42 to 45 amino ac ids . Recent work has 
revealed that N-linked chains are t r i - or t e t r a -an tennary 
and contain in terna l lactosamine (GlcNAc-Gal) repeats ; 
however no 0-linked sugar has been detected (Howe et a l . , 
1988). The receptor does not appear to be phosphorylated 
either in the presence or absence of bound l lgand 
(Mellman et a l . , 1988). 
1 
I T S a a 
29 aa 
COOH 
47 aa 
J 
Fig . 1: Structure of the mouse macrophage-lymphocyte IgGl/IgG2b 
Fc receptor (mFcRII). 
The amino acid sequence was deduced from the 
cDNA clone pFcR13, and the insert ion in the membrane 
derived from biochemical determinations of receptor 
s t ruc ture . 
12 
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Characterization of murine Fc receptor cDNA clones : 
Using amino acid sequence data derived from the 
purified J774 and S49.1 T cell receptor, several cDNA 
clones encoding the murine FcR have been isolated and 
sequenced. 
The method used by Ravetch et a l , (1986) to 
clone the FcR, was to construct an oligonucleotide probe 
based on N-terminal sequence of protein purified by 
affinity chromatography on MAb 2.AG2-Sepharose. This 
method resulted in the isolation of two genes that encode 
related FcR isoforms. One of these, referred to as oC, is 
expressed in va r iab le amounts only in macrophage cell 
l ines , whereas the second gene, referred to as p , is 
expressed in v i r tua l ly a l l mFcRII-positive cells including 
macrophages, B cells and T cells ( Ravetch et a l . , 1986; 
Lewis et a l . , 1986 ) . These genes encode transmembrane 
proteins with an in te rna l ly repeated domain each 
containing two glycosylation s i tes , and a potential 
in t rachain disulphide loop of 42 to 45 amino ac ids . This 
predicted s t ructure is consistent with in vivo label l ing 
studies which have suggested the presence of four N-linked 
glycosylation sites ( Green et a l . , 1985 ) . While the 
ex t race l lu lar domains of the oL and p genes are 95 percent 
14 
homologous, the transmembrane and cytoplasmic domains 
encoded by the two genes are totally different ( Fig . 2 ) , 
an indication that the different functions of lymphocyte 
and macrophage FcR's may derive in par t from different 
s ignal ing mechanisms. 
There i s , however, s t i l l another level of 
complexity in this gene system, since there appear to be 
cell-specific splicing mechanisms tha t may resul t in 
altered protein products . Two p gene t r ansc r ip t s pi and 
p2 have been identified by Ravetch et a l . (1986). 
Although the p gene is t ranscr ibed in both lymphocyte and 
macrophage cell l ines , detailed ana lys i s of a T cell 
t ranscr ip t (P-,) revealed an addi t ional 138 nucleotides, 
which result in an insert ion of A6 amino acids in the 
cytoplasmic domain of Fc^Rpi ( Ravetch et a l . , 1986 ) . 
This was found to be well in agreement with the microsome 
digestion experiments which demonstrated the receptor to 
be a transmembrane protein with a re la t ively large 
cytoplasmic t a i l , 10-15K in length, recognized by a 
par t i cu la r ant i - receptor monoclonal antibody designated C14 
( Green et a l . , 1985 ) . On the other hand, the 
cytoplasmic domain of the receptor obtained from a P388D1 
cDNA l i b r a r y , 47 amino acid residues long, corresponded 
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16 
to approximately 6K in molecular weight. In addi t ion, 
ribonuclease protection experiments have shown that p i 
t ranscr ip t is seen in both T cell and B cell l ines , and not 
in the P388D1 or RAV/ 264,7 macrophage cell l ines and most 
probably ar ises from an a l te rna t ive splicing pathway for 
the p gene. The ear ly macrophage l ines P388 and 
WEHI 3A have p t r ansc r ip t s of the same apparent mobility 
as the lymphocyte cell l ines , and this similari ty suggests 
that pi splicing may be developmentally regulated during 
macrophage maturat ion. The consequences of the insertion 
are not understood, but it is possible that the longer 
cytoplasmic domain in pi Fc^R ( compared to p2 t ranscr ip t ) 
in terac ts differently with cytoplasmic or membrane proteins 
involved in s ignal t ransduc t ion . Since no mFcRI specific 
monoclonal antibodies a re yet ava i lab le and the expression 
of protein from transfected cDNA has proved unsuccessful 
( Ravetch et a l . , 1986 ) , it cannot be said with cer ta inty 
that the monomeric IgG2a receptor ( mPcRI ) whose 
expression also appears to be limited to mouse macrophages, 
is encoded by the OC cDNA. 
Unique features of the Fc receptor signal sequence : 
The sequence of pFcRlS ( encoding mFcRII ) has 
been found to contain an a typica l amino terminal s ignal 
17 
sequence since there are three potential s ta r t sites for 
t rans la t ion at positions -13, -29 and -39. Each of these 
in i t ia tor methionines begins a possible functional s ignal 
and none is associated with any consensus nucleotide 
sequence thought to represent preferred s ta r t sites (Lewis 
et a l . , 1986). Cell free t r ans la t ion of in vitro t ranscr ibed 
pFcRlS mRNA (using pGEM vectors) has demonstrated that 
t rans la t ion can, in pr inc ip le , be in i t ia ted at any of the 
methionines (Mellman et a l . , 1988). In reticulocyte 
lysa tes , ini t iat ion occurs with a s ta r t site at Met .._ or 
to a lesser extent at Met_2g whereas in wheat germ 
lysates ini t iat ion appears to be favoured at Met__g. 
Irrespect ive of which in i t i a tc r methionine is used, 
however, t rans la ted FcR is efficiency inserted into dog 
pancreas microsomes, glycosylated and i t s s ignal cleaved 
to yield the same polypeptides. Thus, the FcR mRNA 
appears to encode three functional s ignal sequences, which 
nevertheless generate ident ical glycoproteins after 
t ranslocation across the RER; the biological significance of 
this observation being unknown. 
Differential expression of murine Fc receptors: 
The expression of protein corresponding to each of 
the three receptor cDNA's has been obtained in vitro by 
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t rans la t ion of synthetic mRNA's in the presence of dog 
pancreas microsomes. The three receptor isotypes could be 
dist inguished on the bas is of molecular weight ( p^-53K; 
p-2 - 47K; CX -45K) and differential react ivi ty with 
anti-mFcRII ant ibodies . A xenogeneic rabbi t antiserum to 
mFcRII, which recognizes ext racel lu lary oriented 
determinants was found to immunoprecipitate the p^ , P2 
and X^ t rans la t ion products , whereas the ra t monoclonal 
antibody C14 (Green et a l . , 1985) directed towards the 
receptors cytoplasmic domain recognized p-1 and p-2 but 
not'-c", in accordance with the sequence differences between 
these receptor species (Fig. 2 ) . 
Proteins, corresponding exactly to those obtained 
by cell free t rans la t ion in presence of microsomes have 
•f 
also been immunoprecipitated from a var ie ty of cell l ines 
35 pulse labelled with [ S] methionine for 10 min, conditions 
which would label only immature HER forms. In the 
lymphocyte l ines (A20/2J B cells; 549.1 T ce l l s ) , and in 
the J774 macrophage l ine , p-1 was clearly the predominant 
receptor species synthesized although some lower molecular 
weight bands , including one corresponding in molecular 
weight to p-2 , were also observed as minor components. 
In P388D1 macrophages and in thioglycoUate elicited 
peritoneal macrophages the predominant receptor species 
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corresponded to p - 2 . All labelled bands i rrespect ive of 
molecular weight were immunoprecipitated with equal 
efficiency by both ant ibodies , but none corresponded in 
mobility to the t rans la t ion product derived fromolcDNA. 
Thus, although the macrophages examined expressed 
t r ansc r ip t s that apparent ly contained oC-specific sequences, 
functional expression of anC<" protein could not be detected. 
It is important to note that by analys ing the precursor 
RER forms of the various receptors, these experiments 
should have detected in t race l lu la r cX", even if it failed to 
be t ransported to the cell surf ace. or was rapid ly degraded 
after synthes is . Although it is too ear ly to conclude that 
t h e ' X - s p e c i f i c t r ansc r ip t s are steri le i . e . , unable to 
program the t rans la t ion of protein, it is clear that the 
predominant form of mFcRII expressed by mouse 
macrophages and lymphocytes corresponds to either p-1 
or p-2. 
Functional expression of mFcRII: 
It has been possible to obtain both t ransient and 
permanent expression of mFcRII using B-1 and p-2 cDNA's 
transfected into COS or CFJO cells (Mellman et a l . , 1988). 
mFcRII is also functionally active even when expressed in 
fibroblast l ines , which normally do not express FcR, 
indicat ing that the receptor act ivi ty does not require the 
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involvement of any other macrophage or lymphocyte specific 
proteins . In an attempt to identify which domains are 
important for the var ious functional act ivi t ies of the 
receptor, na tura l ly occurring site directed mutagenesis 
experiments will be of considerable in teres t . A permanent 
CHO line has a l ready been generated using one such 
mutant, from which the ent i re cytoplasmic t a i l was 
deleted (Mellman et a l . , 1988). Using both 
immunofluorescence and quant i ta t ive assays for immune 
complex uptake, it appears that this deletion subs tan t ia l ly 
interferes with the abi l i ty of the mutant receptor to 
mediate in ternal izat ion and for delivery to lysosomes. 
Thus the FcR cytoplasmic t a i l , although capable of 
considerable sequence heterogeneity, appears to be 
necessary for endocytosis. It is yet not c lear , however, 
whether it is the in i t i a l internal izat ion step or the 
subsequent t ranspor t from endosomes to lysosomes that is 
blocked in the mutant cell l i nes . 
The Fc receptor is a member of the immunoglobulin gene 
family: 
The ex t race l lu la r domain of the receptor was 
found to contain four regular ly spaced cysteine residues 
which define two in terna l sequence r epea t s . The sequences 
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directly surrounding these cysteines show significant 
homology to sequences associated with V and/or C domains 
of immunoglobulin molecules, as v/ell as other members of 
the immunoglobulin gene super family (Lewis et a l . , 1986; 
Barclay et a l . , 1987). However, the number of amino 
acids between the two domains was only 42-4'», considerably 
shorter than that typical ly found in the constant and 
var iab le domains of immunoglobulin molecules (usual ly 
70-80 res idues) . These shortened domains bear 
considerable similari ty to those found in at least one other 
immunoglobulin like molecule, the neural cell adhesion 
molecule N-CAM (Hemperly et a l . , 1986) and presumably 
result from the deletion of p s t rands from within the 
immunoglobulin fold, although the functional significance 
of this arrangement is unknown. Thus, it is clear that 
both the l igand and the receptor itself belong to the same 
family of molecules.. Since most probably the binding 
groups and binding s i tes , respect ively, are exposed on the 
surface of the coresponding molecules, the receptor- l igand 
interaction might be similar to the interdomain in teract ions 
of Ig molecules. Considering the modes of interact ions by 
which members of the Ig super family associate with each 
other (Anderson et a l . , 1988), it may be supposed that 
IgG - IgG FcR interaction corresponds to the heterophilic 
in tercel lular type v/hen opsonized target cells interact 
with FcR - bear ing effector cells (ADCC) . 
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Functions of the murine IgGl/IgG2b Fc receptor (mFcRII): 
The binding of immune complexes to the receptor 
on neutrophils and macrophages t r iggers var ious cel lular 
responses, including phagocytosis ' which leads to the 
clearance of ant ibody-ant igen complexes and the 
l igand- t r iggered transmission of s ignals across the plasma 
membrane, which result in a l te ra t ions in secretion, 
exocytosis and cel lular metabolism. On lymphocytes, they 
are presumed to have a role in the modulation of antibody 
production by B cells (Mellman et a l . , p . 9 8 8 ) . 
a) Fc receptor-mediated endocytosis: 
The macrophage IgGl/IgG2b FcR are found to 
mediate two important forms of endocytosis; 
(i) Pinocytosis of soluble ant ibody-ant igen complexes, 
(ii) Phagocytosis of l a rge IgG coated par t i c les . 
Normal pathway of receptor mediated endocytosis 
i . e . accumulation of the receptor l igand complexes at 
clathrin-coated p i t s , in ternal izat ion in coated vesicles and 
subsequent delivery of the l igand to acidic endosomes and 
finally to lysosomes for degradat ion has been followed 
(Mellman et a l . , 1984; Ukkonen et a l . , 1986; Mellman 
et a l . , 1986; Mellman et a l . , 1987). The factors governing 
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the ra te of FcR mediated in ternal izat ion of immune 
complexes include (a) the size of the complex (b) the 
multivalency by which it binds to FcR (c) the mean life 
time a complex remains on the cell surface subsequent to 
binding (Segal et a l . , 1983). Internal izat ion of these 
multivalent IgG complexes is accompanied not only by the 
in t race l lu la r degradation of the l igand but also by a net 
decrease in the number of plasma membrane Fc receptor 
and accelerated ra te of membrane receptor turnover. While 
the macrophage FcR in control cells turns over with a 
tV2 
of approximately 15-20 hr , in cells exposed continuously to 
immune complexes, the t^/^ is reduced to less than 5 hr 
(Mellman et a l . , 1988). As can be seen in Fig. 3, 
monovalent FcR-Fab (derived from the anti-receptor 
antibody 2.4G2) are in ternal ized , delivered to endosomes 
and rapid ly returned to the cell surface without requir ing 
t rans i t through lysosomes (Mellman et a l . , 198A), whereas 
aggregated 2.AG2 Fab polyvalent ant ibody-ant igen 
complexes are t ranspor ted to lysosomes and degraded 
(Mellman et a l . , 198A; Ukkonen et a l . , 1986). It appears 
that the receptor aggregated by multivalent l igands 
governs i ts fate on in te rna l iza t ion . This type of 
regulation may be important in a t tenuat ing macrophage 
function at sites of chronic inflammation in i ts role in 
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t r igger ing the release of inflammatory and cytotoxic 
agents . FcR-mediated phagocytosis also leads to the 
removal of receptors from the plasma membrane and 
intralysosomal receptor degradat ion (Mellman et a l . , 1983). 
That the regulat ion of the pathway of in t race l lu la r 
t ranspor t of FcR is governed by the valency of bound 
l igand suggests a possible mechanism governing membrane 
protein traffic in genera l . Many other receptors , such as 
the low density l ipoprotein and t ransfer r in receptors , 
which normally recycle rap id ly during endocytosis can also 
be diverted to lysosomes if allowed to interact with 
ar t i f ic ia l non-dissociat ing multivalent l igands ( e .g . polyclonal 
ant i-receptor antibody) (Mellman et a l . , 1987). It can 
thus be concluded tha t sl ight a l tera t ions in the 
aggregation s ta te or the degree of oligomerization of 
membrane receptors may influence their pa t te rns of 
in t race l lu la r t r anspo r t . However, it is not at a l l clear 
whether the s ignal generated by such l igand-induced 
changes in qua te rnary s t ructure is manifested at the level 
of receptors cytoplasmic, membrane-spanning, or 
ext race l lu lar domain. 
b) Transmembrane signall ing 
The second set of functions, t r iggered by the 
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binding of l igand to generate a transmembrane s ignal 
include a localized reorganizat ion of act in-containing 
microfilaments directly beneath the plasma membrane at the 
site of par t ic le attachment ( faci l i ta t ing phagocytosis) , 
release of mediators of inflammation such as leukotrienes 
and pros tag landins , induction of neutra l hydrolases 
(e .g . plasminogen ac t iva to r ) , and the release of hydrogen 
peroxide and other oxygen intermediates that mediate 
antibody-dependent cel lular cytotoxicity (ADCC) (Unkeless 
et a l . . 1981). 
The mechanism of FcR-mediated t-ansmembrane 
s ignal l ing is not c lear . Although kinase - l ike 
phosphorylation events have been ruled out for the 
receptor, it appears tha t the s ignal is produced by forming 
an ion channel , thereby depolarizing the macrophage and 
2+ 
causing a t rans ient increase in the in t race l lu la r free Ca 
(Young et a l . , 1984), as in the case of acetylcholine 
receptor. It has been suggested that the receptor may 
function as a l igand dependent ionophore (Young 
et a l . , 1983). The ionophore does not discriminate 
between Na and K* and shows low permeability to Ca^"^. 
However, more recent data shows that these ion fluxes do 
not effect the ra te of phagocytosis (Di Virgilio et a l . , 1988), 
and other functions such as phagosomal acidification or 
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superoxide anion generation are independent of changes in 
membrane potential (Pfefferkorn, 1984). Moreover, the 
receptor being a transmembrane protein with a single 
highly hydrophobic membrane-spanning segment, places 
some const ra ints on the appl icabi l i ty of the ion channel 
concept. 
Function of the IgGl/IgG2b receptor on lymphocytes: 
On lymphocytes, the receptor may play a role in 
the regulation of immune response. Passive administrat ion 
of antibody aga ins t an antigen resul ts in the inhibi t ion of 
specific immune response of the antibody agains t tha t 
ant igen. Binding of IgG to IgG secreting B cells directly 
supresses IgG production (Sherr et a l . , 1989). Fur ther , it 
has been found that the Fc portion of the antibody is 
necessary for such inhibi t ion to take p lace . The 
inact ivat ion of B lymphocytes by FcR is given by the 
t r i pa r t i t e inact ivat ion model (Fig. 4) , which proposes that 
ant igen-ant ibody complexes in teract with antigen sensitive 
cells when a determinant binds to the antigen receptor and 
the Fc portion of antibody binds to FcR. Thus, a cross 
l inking of FcR and antigen receptor takes place which 
inact ivates immunocompetent cel ls . It has been shown that 
FcR-positive B cells can be tr iggered to mature and 
IgG antibody 
Fig . 4: The inac t iva t ing complex made up of ant igen, 
antibody, and specific B cells referred to as the 
t r i pa r t i t e inact ivat ion model. 
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proliferate by specific antigen or by the binding of surface 
IgM with the F ( a b ' ) fragment of an anti-IgM monoclonal 
antibody (Bijsterbosch and Klaus, 1985). However, when 
intact anti-IgM was used instead of the FCab')^ an 
addit ional s ignal v/as provided preventing the proliferative 
response necessary for terminal differentiation and 
antibody synthes is . The effect was beleived to be 
mediated by the cross l inking of surface Ig with FcR 
(Phil l ips and Parker , 1984) and subsequent inhibit ion of 
the phosphatidyl inositol cascade (Bijsterbosch and 
Klaus, 1985). 
Structure and cDNA cloning of human Fc receptor (hFcR): 
Human monocytes, granulocytes and lymphocytes 
are well known to express at least three distinct FcR types 
(see Table I) (Anderson and Looney, 1986). 
(a) hFcRI: is a 70K high-aff ini ty receptor for monomeric 
IgG recognized by the monoclonal antibody 32 (Anderson, 
1982; Cohen et a l . , 1983). It is found only on monocytes 
and macrophages and is thus thought to be directly 
homologous to mFcRI, i . e . the monomeric IgG2a receptor. 
(b) hFcRII: l ike mFcRII, it is more widely dis t r ibuted and 
exhibi ts a low affinity for monomeric IgG. It is detected 
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by two monoclonal antibodies (IV.3 and Ku 67) which 
immuno-precipipate a narrow 40K glycoprotein (Looney 
et a l . , 1986; Vaughn et a l . 1985). 
(c) hFcRIII : while there is no known human FcR homologous 
to the murine IgG3 receptor a th i rd hFcR (hFcR-N) has 
been identified on granulocytes and to a lesser extent on 
macrophages (Fleit et a l . , 1982). The receptor exhibi ts a 
very low affinity for IgG and is immunoprecipitated by 
several monoclonal antibodies as a heterogeneous 
•r 
glycoprotein band of A0-70K (Perussia et a l . 1984; 
Fleit et a l . 1982). 
Using the p-2 cDNA pFcR13 as a probe, a cDNA 
encoding a highly homologous FcR from the U937 human 
monocyte cell line has been recently isolated and 
character ized. Expression of th is cDNA (referred to as 
16.2) by transfection in f ibroblasts produces a 40K 
glycoprotein that reacts v/ith the anti-hFcRII reagent 
IV. 3 . A monoclonal an t i -pept ide antibody specific to a 
synthetic peptide encoding a portion of the predicted 
amino acid sequence recognizes IV. 3 - positive cells and 
not IV.3 - negative cel ls . 
The amino acid sequence deduced from this cDNA is 
s t r ik ingly similar to both the (XC and p forms of murine 
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FcR (see Table 2 ) . The ex t race l lu la r domain of the human 
FcR is 70% homologous to both murine sequences. The two 
immunoglobulin-like domains a re exactly conserved although 
two of the four N-linked glycosylation si tes found in the 
murine species have been lost by amino acid subst i tu t ion. 
At the same time, however, the human receptor appears to 
be somewhat 'chimeric ' in na tu re . I ts predicted s ignal 
sequence as well as the 5' unt rans la ted region of clone 
16.2 are decidedly ' OC l i k e ' , although the membrane 
spanning domain is 50% homologous to murine p and thus 
completely dist inct from OC . The cytoplasmic t a i l of the 
human FcR is completely unique, being unlike (X, p or any 
other known protein sequence. 
While the expression data and the sequence of the 
ex t race l lu lar and membrane spanning domains indicate that 
the human receptor encoded by clone 16.2 is directly 
homologous to mFcRII, the differences in their cytoplasmic 
domains suggest that these two molecules may be 
functionally d is t inc t . While further attempts to isolate 
such cDNA's from the U937 l i b r a r y have proved unsuccessful, 
two addi t ional cDNA's have recently been identified from a 
human placental cDNA l ib r a ry (Mellman et a l . , 1988). 
Although or iginal ly screened to identify cDNA's 
corresponding to the syncytiotrophoblast FcR, which 
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mediates the t r ansce l lu la r t ranspor t of maternal IgG, the 
deduced sequences obtained are s t r ik ingly similar to 
sequences charac te r i s t i c of macrophage lymphocyte FcR. 
Presumably, these cDNA's were derived from placental 
macrophages ( e .g . Hofbauer cells) or lymphocytes as 
opposed to placenta l epi thel ia l cel ls . One of these 
predicts a sequence, which is very similar to that encoded 
by 16.2, with only a few amino acid subst i tut ions except 
that it has a dist inct 3 ' un t rans la ted region. The 
second, however, is direct ly homologous to the murine FcR 
sequences throughout i . e . the cytoplasmic domains of the 
human and murine receptor are s imilar . Fur ther , 
character izat ion of the expression of these molecules as 
well as the ana lys i s of the functional act ivi t ies associated 
with them will be needed to apprecia te the significance of 
this extended but closely related family of membrane 
receptors . 
Soluble FcR Molecule: 
Several inves t igators have described soluble 
factors present in cell free culture superna tan ts or 
c i rculat ing in serum which bind immunoglobulin via the Fc 
fragment ( Ig-b inding factors or IBF) and are capable of 
positively or negatively influencing the immune response. 
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Distinct IBFs have now been reported for a l l Ig isotypes 
and subclasses (see Table 1) . The best studied are those 
synthesized and released from human or rodent FcR T 
lymphocytes (Fridman and Golstein, 1974; Fridman 
et a l . , 1984; Ishizaka, 1984). The synthesis and secretion 
of IgM and IgG antibodies are regulated in fact, by the 
secretion of soluble IBF's from FcR T cells (Fridman 
et a l . , 1984), while other IgE binding T-cell factors 
selectively regula te the IgE response (Ishzaka, 1984; 
Spiegelberg, 1981). IgE-potent iat ing factors or 
IgE-suppresive factors are formed and released depending 
on the isotypic restr ict ion of the membrane FcR, and on 
the exposure to addi t ional T-cell factors affecting their 
abi l i ty to glycosylate ( I sh izaka , 1984). Production of IgG 
by B cell hybridoma and proliferation of these cells and 
i t s hybridoma T2D4 (Brunati et a l . , 1988). In addi t ion, 
a soluble FcR is secreted from stimulated B cells which 
reacts with 2.4G2 and is thus antigenically similar to the 
cell associated form of IgGl/IgG2b FcR, however, the 
function of this FcR is not known (Pure et a l . , 1984). B cell 
activation by l ipopolysaccharide also resul ts in the 
expression of a unique FcR epitope, recognized by 
monoclonal antibody 6B7c which may correlate with the 
release of the soluble form of the receptor. 
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All these facts strongly suggest that the IgG-BF 
are derived from the cell surface FcR. However, they do 
not exclude the possibi l i ty that some IgG-BF may be 
secreted without being first anchored in the membrane. 
From the review of the exist ing l i t e r a tu re , 
presented above on the Fc receptor, it seems that the 
receptors from different sources may differ s ignif icantly in 
their molecular and functional propert ies . However, 
studies on receptors from species other than murine, human 
and guinea pig are yet to be carr ied out. Moreover, 
these studies have been mainly confined to macrophages 
and macrophage cell l i nes . Further , despite the known 
functional significance of self association of the receptor, 
i t s aggregat ing tendency in aqueous buffer devoid of 
detergent remains to be systematically inves t igated . With 
this aim in view, we isolated the receptor from hitherto 
uninvest igated source i . e . goat per ipheral blood 
lympocytes, and studied the interact ion with i ts l igand 
under different conditions of pH and ionic s t rength. 
To unders tand the possible relat ionship between 
receptor function and s t ruc ture , the character izat ion of 
receptor binding s i tes , the location of in teract ing groups 
on Ig Fc, as well as the possible role of conformation, 
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both of the l igand and receptor, will be s tudied. 
Biochemical studies of soluble Fc^^Rs, or immunoglobulin 
factors, will lead to a better understanding of the 
immuno-regulatory role of these molecules. 
II. EXPERIMENTAL 
A. Materials 
1. Prote ins : 
Bovine serum a lbumin (lot No. lOOF-0294) . 
2 . Chromatographic media: 
Diethyl aminoe thy l (DEAE) ce l lu lose (lot No. 59C -
0243) and Sepharose AB were p u r c h a s e d from Sigma 
Chemical Company, St . Lou i s , Mo., U .S .A. ; Blue d e x t r a n 
and Sephadex G-200 were o b t a i n e d from P h a r m a c i a Fine 
Chemica l s , U p p s a l a , Sweden. 
3 . Reagents used in the i so la t ion of lymphocytes and 
membrane prote ins: 
His topaque - 1077 (lot No. 45D - 6174), nonide t 
P-40 (lot No. 103F - 0594), p h e n y l m e t h y l su l fonyl f luor ide 
(lot No. 103F - 0493) and t r y p a n b lue were o b t a i n e d 
from Sigma Chemical Company, St . Lou is , Mo., 
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ij.S.A.; other reagents used with their sources in 
parentheses are ethylene diamine te t raacet ic acid (BDH, 
Bombay, I nd i a ) , ammonium chloride (E. Merck, Dramstadt, 
Germany) and W.B.C. di lut ing fluid (Glaxo Laboratories 
Bombay, India) . 
4. Miscellaneous reagents: 
Fluorescein isothiocyanate, isomer I (lot No. 
102F - 5045) was purchased from Sigma Chemical Company, 
St. Louis, Mo., U.S.A., sodium deoxycholate from Fluka, 
Switzerland and cyanogen bromide from Sisco Research 
Laboratories, Bombay, Ind ia . 
All other reagents were of ana ly t ica l grade and 
were used without further purif icat ion. Glass dist i l led 
water was used throughout the s tudy. 
B. Methods 
1. Preparation of solutions: 
(a) Copper reagent 
The reagent was prepared by mixing 4% (W/V) 
sodium carbonate, 4% (W/V) sodium potassium t a r t a r a t e and 
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2% (W/V) copper sulphate in the ratio of 100 : 1 : 1. 
(b) Folin-phenol reagent 
The Folin-phenol reagent was prepared by the 
method of Folin and Ciocalteu (1927). Hundred grams of 
sodium tungs ta te , 25 g of sodium molybdate, A8.2 ml of 
85% orthophosphoric acid , 100 ml of concentrated 
hydrochloric acid and 700 ml of dist i l led water were 
mixed together and the contents were refluxed gently in a 
round bottom flask covered with black paper for ten hours . 
After cooling, 128.88 g of lithium sulphate , 50 ml of 
dist i l led water and a few drops of l iquid bromine solution 
were added. The mixture was boiled for 15 minutes to 
remove excess bromine. The solution was cooled, filtered 
and diluted to one l i t r e . The yellow coloured reagent was 
stored in dark bottles and the stock solution diluted five 
times with dist i l led water before use . 
(c) Dye solution 
Coomassie b r i l l i an t blue G-250 (100 mg) was 
dissolved in 50 ml of ethanol and to this solution was 
added 100 ml of 85% (V/V) orthophosphoric acid . The 
volume was then made to one l i t re with dist i l led water . 
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2. pH measurements: 
pH measurements were carr ied out on Elico d ig i ta l 
pH meter (model LI - 120) in conjunction with an Elico 
glass electrode and sa tura ted calomel electrode. The least 
count of the pH meter was 0,01 pH un i t s . The pH meter 
was routinely ca l ibra ted with 0.05 M potassium hydrogen 
pthala te buffer pH 4.0, in the acidic pH range , and with 
0.01 M sodium te t rabora te buffer pH 9.2, in a lkal ine 
pH range . 
3. Optical measurements: 
Absorbance of the solution in the vis ible range 
was measured on photochem colorimeter (model C-110). In 
the ul t raviolet region l ight absorption measurements were 
made on single beam CECIL spectrophotometer (model CE-202) 
and on CECIL double beam spectrophotometer (model CE-594) , 
Fluorescence measurements were performed on Shimadzu 
spectrofluorophotometer (model RF-540), using quartz cell 
of 1 cm path length. The slit width was 10 nm. 
4. Protein estimation: 
(a) Lowry's method 
Protein concentration was.^ routinely determined 
41 
by the method of Lowry et a l . (1951) using crys ta l l ine 
bovine serum albumin as s t anda rd . Typical ly, 1 ml of 
protein solution was mixed with 5 ml of copper reagent . 
After 10 minutes, 1 ml of Folin-phenol reagent was added 
and' the solution incubated for 30 minutes at room 
temperature for the development of colour. The 
absorbance was read at 700 nm. The l inear curve shown 
in Fig . 5 was obtained by the method of least squares and 
was found to fit the equation, 
(O-D-^yOOnm = -^^ "^ (mg.protein) + 0.041 (i) 
(b) Modified Lowry's method 
Protein concentration in presence of detergent 
was determined by modified Lowry's method as described 
by Cabib and Polacheck (1984). To 1ml of protein 
solution, was added 0.1 ml of deoxycholate and 0.1 ml of 
100% TCA. After shaking , the mixture was kept in ice for 
45 minutes and centrifuged at 600g for 50 minutes. The 
precipitat ion protein was washed with chilled 20% TCA 
solution twice. The precipi ta te was then dissolved in 1 ml 
of 0.1 M NaOH and 1 ml of copper reagent (3% Na^co, 
in 0.1 M NaOH, 4% sodium potassium t a r t a r a t e 
and 2% copper sulphate in the ra t io 9.6 : 0.2 : 0.2 
by volume) was added. Th^ solution was 
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F i g . 5 : C a l i b r a t i o n , c u r v e for the es t imat ion of p ro te in 
concen t r a t i on by t h e method of Lowry et a l . (1951) 
u s ing BSA a s the s t a n d a r d p r o t e i n . The s t r a i g h t 
l i n e was d r a w n by the method of l e a s t s q u a r e s 
a n d f i t s t he e q u a t i o n : 
(O.D.) 700nm 1.97 [ m g . p r o t e i n ] + 0 .041. 
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incubated at 37°C for 10 minutes and then 0.1 ml of 
Fol in ' s reagent was added. The mixture was incubated 
again at 37'^ C for 15 minutes. The colour intensi ty was 
read at 700 nm agains t blank prepared in the same 
manner. The l inear curve shown in Fig . 6 was obtained 
by the method of least squares and was found to fit the 
equation, 
(O.D.)_-- = 0.0018 (xxg.protein) + 0.12 ( i i ) 
/uunm ^^ 
(c) Dye binding method 
Five ml of dye solution was added to 1 ml of 
protein solution and colour intensi ty was read at 580 nm. 
The cal ibrat ion curve shown in Fig . 7 was obtained by 
using bovine serum albumin as s t anda rd . The s t ra ight 
line obtained by the method of least square analys is was 
found to fit the equation, 
^°'°*^580nm ^ ^'^ (mg.protein) + 0.0056 (il l) 
5. Ion exchange chromatography: 
Ion exchange chromatography was performed 
using DEAE-cellulose. The resin was swollen in dist i l led 
water. It was t reated with 0.1 N NaOH for one hour at 
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Fig . 6: Calibration curve for the estimation of protein 
concentration by the method of Cabib and Polacheck 
(1984) using BSA as the s tandard protein. The 
s t ra ight l ine v/as drav/n by the method of least 
squares and fits the equat ion: 
(O.D.) 7oonm ^ O-OO^^  [pg.prote in] + 0.12. 
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F i g . 7 : C a l i b r a t i o n c u r v e for the es t imat ion of p r o t e i n 
concen t r a t i on by dye b i n d i n g method (Bradfo rd , 
1976) u s i n g BSA a s the s t a n d a r d p r o t e i n . The 
s t r a i g h t l i n e was d r a w n by the method of l e a s t 
s q u a r e s and f i t s t h e e q u a t i o n : 
(O.D.) SSOnm 3-5 ( m g . p r o t e i n ] + 0.0056, 
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room temperature, washed with dist i l led water t i l l pH 
became neut ra l , and then treated with 0.1 N HCl for an 
hour. The regenerated resin was washed extensively with 
dist i l led water to remove excess of acid . I t was packed 
in a column (1.2 x 9 cm) and equi l ibra ted with the 
operating buffer. 
6: Gel filtration: 
Gel fi l tration experiments were performed on a 
Sephadex G-200 column. The column was packed according 
to the method of Ansari and Salahuddin (1973). About 
10 g of gel was allowed to swell in dist i l led water for 
about 6 hours in an oven. The fine par t ic les were then 
removed by decantat ion. This process was repeated 
several times unt i l the gel was free from fine pa r t i c l e s . 
A glass column (2.28 x 100 cm) was taken and washed 
with detergent , chromic acid and finally with dist i l led 
water. The r ad ius of the column was determined to be 
1.14 cm. 
After determination of the r ad iu s , a small amount 
of g lass wool, previously boiled in water, was placed at 
the bottom of the column with the help of a glass rod. 
Few glass beads were placed on the 'surface of the glass 
wool. One thi rd of the g lass column was then filled with 
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operating buffer keeping the outlet closed. An extension 
glass column (1.6 x 61 cm) was fitted on top of the column 
and gel s lurry was then poured slowly into the column, 
through the extension, with the help of a glass rod. As 
the gel settled down, the flow ra te was increased gradual ly 
from 5 ml per hour to 40 ml per hour. The column was 
then equi l ibrated with operating buffer by passing a 
volume equal to three times of the tc ta l bed volume. 
Uniform packing of the column was checked by passing 
0.2% W/V solution of blue dex t ran . 
The operating buffer on top of the column was first 
drained off and 2-4 ml of the sample, containing 30-60 mg 
protein, was applied on the column with the help of an 
appl ica tor . The stop cock of the column was then opened 
slowly and the sample was allowed to percolate through 
the upper surface of the gel . As soon as the sample 
entered the gel , the column was rinsed with about 4 ml of 
the buffer solution. The flow ra te of the column was then 
adjusted to 20 ml per hour and the column was connected 
to a reservoir containing operat ing buffer. After rejection 
of discarded volume, fractions of 5 ml were collected and 
protein concentration determined by the method of 
Lowry et a l . (1951). 
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7. Isolation of IgG and preparation of its derivatives: 
In this s tudy, goat IgG was isolated from plasma 
by the method of I r shad et a l . (1981). IgG was 
precipitated as 39% of the total plasma proteins by 40% 
ammonium sulphate fract ionation. After dissolving the 
precipi ta te in minimal . volume of 0.1 M sodium phosphate 
buffer pH 8.0, it was further purified on DEAE-cellulose 
column (2.4 x 9 cm), equi l ibra ted with 0.1 M sodium 
phosphate buffer pH 8.0. Protein eluted as both unbound 
and bound fractions at 0.1 ionic s t rength . The elution 
profile is shown in F ig . 8. Fractions under the peak 
A and B (as represented by bars ) were pooled and the 
amount of protein was found to be about 85 mg. The 
protein obtained after ion exchange chromatography was 
loaded on Sephadex G-200 column (2.28 x 93 cm) 
equi l ibrated v/ith 0.01 M sodium phosphate buffer pH 8.0, 
containing 0.15 M NaCl. As can be seen in Fig . 9, the 
protein emerged as two peaks . The minor peak with Ve/Vo 
of 1.0 probably represents the highermers of IgG. This is 
true because even the dimer of IgG has a molecular weight 
above the exclusion limit of Sephadex G-200 which is 
250,000. (Ref. Pharmacia Biotechnology Catalogue). The 
other major peak (Ve/Vo = 1.43) represents the monomeric 
IgG. The total yield of purified IgG \Mas about 20.5% (see 
Table I I I ) . 
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Fig . 8: Elution profile of 40% ammonium sulphate fraction 
of goat plasma on DEAE-cellulose column. 
About 146 mg. protein in 10 mM sodium 
phosphate buffer pH 8,0, v^as applied on 
DEAE-cellulose column (2.4 x 9 cm) equi l ibrated 
with the same buffer. The bound protein was 
eluted with 0.1 M sodium chlfcride. Protein was 
collected in 5 ml fractions and monitored by the 
method of Lowry et a l . (1951), 
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Fig, 9: Elution profile of protein isolated after ion 
exchange chromatography on Sephadex G-200 
column. 
About -50 mg. protein in 10 mM sodium 
phosphate buffer pH 8.0, containing 0.15 M sodium 
chloride was applied on Sephadex G-200 column 
(2.28 X 93 cm). The protein was eluted in 5 ml 
fractions at a flow ra te of 20 ml per hour and 
monitored by the method of Lowry et a l . (1951). 
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Heat aggregation of IgG 
Aggregated IgG was prepared by the method of 
Schreiber and Haimovich (1983). As most of the ion 
exchange purified protein emerged as a major peak on 
Sephadex G-200 column representing monomeric IgG, the 
above protein was used as such, for heat aggregat ion. 
After making the protein in 0.15 M NaCl at a concentration 
of 7-10 mg per ml, it was heated at 63'^ C for 10 minutes. The 
appearance of turbidi ty in the protein solution indicated 
that monomeric IgG had undergone aggregat ion. However, 
in absence of 0.15 M NaCl or at a concentration higher 
than 10 mg per ml, precipi tat ion occurred soon after 
hea t ing . Similarly, stored IgG also tended to precipi ta te 
on heat ing. Therefore, it is always required to obtain 
heat aggregated IgG from freshly isolated monomeric IgG. 
To verify the presence of heat aggregated 
IgG, i ts elution pat tern was seen on Sephadex G-200 
column (2.28 x 93 cm). As can be seen in Fig. 10, about 
47% of total protein emerged in the void volume of the 
column. This indicated the presence of about A7% 
aggregation of IgG. Thus, the peak at Ve/Vo of 1.46 
represented the monomeric IgG. The total yield of heat 
aggregated IgG was 10.7% (see Table I I I ) . 
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Fig- 10: Elution profile of heat aggregated IgG on 
Sephadex G-200 column. 
About 38 mg. protein in 10 mM sodium 
phosphate buffer pH 8.0, containing 0.15 M NaCl 
was applied on Sephadex G-200 column 
(2.28 X 93 cm). The protein v/as collected in 
5 ml fractions at a flov/ ra te of 20 ml per hour 
and monitored by the method of Lowry et a l . (1951). 
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8. Isolation of lymphocytes from goat blood : 
Lymphocytes from goat blood were isolated by 
density gradient method of Boyum (1984). Freshly 
collected goat blood was centrifuged at 600g for 20 
minutes on Remi R23 centrifuge and the buffy coat was 
collected. It was washed three times with phosphate 
buffered saline (10 mM sodium phosphate buffer, pH 7.4, 
containing 0,15 M NaCl) to remove cytophilic IgG 
(Alexander et a l . , 1978). The buffy coat was then 
diluted in the ra t io of 1 : 1 with PBS and 8 ml of th is 
solution was layered on 3 ml of Histopaque-1077. This 
was centrifuged on Remi T8C centrifuge at 600g for 20 
minutes. The white layer at the interface of Histopaque 
and PBS was aspi ra ted with the .help of a Pasteur pipet te . 
The collected cells were washed with 0.83% NH.Cl to remove 
4 
contaminating red blood ce l l s . The lymphocytes were then 
washed with PBS containing 0.2% sodium azide to inhibi t 
receptor endocytosis (Alexander et a l . , 1979). 
Cell counting 
After isolation, the cells were counted using a 
haemocytometer (Mishell and Shiigi, 1980). The coverslip was 
placed on the haemocytometer and using a Pasteur 
pipette, cell suspension was gently applied between the 
coverslip and the haemocytometer. All the cells in the 
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four large squares were counted. Each square of the 
haemocytometer with coverslip in place, represents a total 
volume of 0.1 mm or 10~ cm . Since 1 cm is equivalent 
to approximately 1 ml, the subsequent cell concentration 
per ml was determined by the following equation: 
Cells per ml = average count per square x 10 (iv) 
If diluted suspension was used, then the count 
was multiplied by the dilution factor. The viable white 
blood cells were quantified by s ta ining cell population 
with t rypan blue. The dye is taken up by non viable 
cells and is excluded by the viable cel ls . 
To 0.5 ml of 0.16% t rypan blue solution in normal 
sa l ine , was added 0.5 ml of the cell suspension. The 
cells were loaded on a haemocytometer and the blue 
stained (dead) and unstained (viable) cells were counted 
separately as described above. 
number of viable cells x l 0 0 . . . ( v ) 
Percent viable cells = 
total number of cells 
The total number of cells include both the dead 
•f 
and the viable cel ls . 
9. Isolation of lymphocyte membrane: 
For the isolation of lymphocyte membrane, cells 
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were subjected to hypotonic lysis (Coligan and Kindt, 1986). 
The cells were suspended in 10 mM Tris-HCl buffer pH 7.0, 
containing 1 mM MgCl2 and 1 mM KCl, and frozen by 
keeping in the refr igerator for about one hour. The cells 
were then thawed and the pH increased to pH 8.0 by 
adding solid Tr is . The cells were then dis integrated in a 
homogenizer with a t ight fitting pestle for 3 minutes. The 
unbroken cells , nucleus and cell derbis were removed by 
centrifugation at 9009 on Remi R23 centrifuge for 10 
minutes. The supernatant obtained was then centrifuged 
at 50,000 rpm on Beckman ultracentr ifuge L855M for 1 hour 
to pellet the membrane. The membrane pellet was then 
solubilized in solubilizing buffer (PBS containing 
0.5% NP-40, 2 mM PMSF and 3 mM EDTA) . 
10. Preparation of affinity media: 
Specific protein was linked to Sepharose 4B for 
the preparat ion of affinity gel by the method of 
Cuatrecasas and Anfinsen (1970). For covalent attachment 
of protein to Sepharose 4B, the gel was act ivated with 
CNBr (300 mg CNBr per ml of gel) at A°C adjusting the pH 
to pH 11 by adding small amounts of 4 ^ NaOH. After the 
CNBr had completely dissolved and the pH was s table , the 
gel was washed extensively first with chilled water to 
remove excess of CNBr and then with chilled coupling 
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buffer (0.2 M sodium carbonate buffer pH 8.2, containing 
0.1 M NaCl). The protein to be coupled (1-2% solution) 
was taken in the coupling buffer, added to the activated 
gel and incubated at 4°C for two days . The gel was then 
washed and protein concentration determined in the 
washings to calculate the unbound protein. The gel was 
then incubated with 0.2 M glycine in coupling buffer for 4 
hours at room temperature, to block the free activated 
groups. After washing with dis t i l led water, the activated 
gel was stcred in PBS containing 0.02% azide. 
11. Isolation of IgG binding protein: 
Immunoglobulin binding proteins were isolated 
either after the solubilization of whole cells or from the 
isolated membrane. Lymphocytes or the membranes were 
solubilized in PBS pH 7.4, containing 0.5% NP-40, 2 mM 
PMSF, 3 mM EDTA, for 1 hour in cold. Then the mixture 
was centrifuged at 600g for 30 minutes on Remi R23. The 
clear supernatant was incubated with 15 ml of aggregated 
IgG-Sepharose 4B overnight in cold. The gel was then 
packed in a syringe (1.4 x 10cm) and washed with chilled 
•f 
PBS containing 0.1% NP-40. The protein was eluted with 
0.5 M acetic acid containing 0.1% NP-40. The fractions 
(3 ml each) were collected in tubes a l ready containing 
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0.5 ml of 2 M sodium carbonate to neutral ize the eluted 
protein without de lay . The protein was estimated by the 
method of Cabib and Polacheck (1984). The eluted 
fractions were pooled, concentrated and dialysed agains t 
10 mM sodium phosphate buffer pH 7.4. The solution was 
then incubated with the same affinity gel over night and 
washed with PBS containing 0.1% NP-40. The bound 
protein was eluted with 0.5 M acetic acid containing 
0.1% NP-40. 
Use of sodium deoxycholate for the solubilization 
of membrane proteins was also t r i ed . It has the 
advantage over NP-40 tha t it does not absorb in the 
ul t raviolet region, optical density of 5% sodium 
deoxycholate solution being 0.13 at 280 nm . However, 
sodium deoxycholate precipi ta tes in acidic pH and forms 
large micelles (Tanford and Reynolds, 1976). 
12. Detection of Ig binding protein on goat lymphocytes by 
the binding of FITC-conjugated IgG: 
The specific binding of immunoglobulin to goat 
•t 
per ipheral blood lymphocytes was detected by fluorometric 
assay following the method of Schreiber and Haimovich (1983). 
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(a) Preparation of FITC-conjugated IgG 
For the p r e p a r a t i o n of FITC con juga t e , t he 
immunoglobul in so lu t ion was f i r s t d i a l y s e d a g a i n s t 0.2 M 
sodium c a r b o n a t e buffer pH 9 . 0 . A f resh so lu t ion of FITC 
was p r e p a r e d by d i s s o l v i n g i t in e t h a n o l in o r d e r to get a 
solut ion of c o n c e n t r a t i o n 2.5 mg per ml. To the IgG 
solut ion (5-10 mg pe r ml) in 0.2 M sodium c a r b o n a t e 
buffer pH 9 .0 , FITC so lu t ion was added k e e p i n g about 
25 / ^g of FITC for each mi l l ig ram of IgG. This was 
i n c u b a t e d for 30 minutes a t 37°C with c o n s t a n t shak ing . 
The r e s u l t i n g FITC-IgG so lu t ion was s e p a r a t e d from 
u n r e a c t e d FITC by ge l f i l t r a t i o n on Sephadex G-200 column 
(2.2 X 20 cm) . 
The p ro t e in c o n c e n t r a t i o n was c a l c u l a t e d by t h e 
he lp of the e q u a t i o n . 
'^280nm " ^ ' ^ ^ ^ \ 9 5 n m 
1 .4 
(v i ) 
w here A„pr, 3"<^ ^LQB ^^® o p t i c a l d e n s i t i e s a t 280 a n d 495 nm 
r e s p e c t i v e l y . 
The molar r a t i o of f luorophore to p ro te in i . e . F /P 
was computed with the he lp of fol lowing e q u a t i o n , 
495 nm 150,000 
F /P = X ( v i i ) 
73,000 FITC IgG cone . 
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where 150,000 is molecular weight of IgG and 73,000 is the 
molar extinction coefficient for the fluorescein group. The 
F/P ra t io calculated by the above equation was general ly 
found to be between 2-3. 
The conjugated IgG fractions were aggregated by 
heating at 63°C for 10 minutes and the aggregates were 
isolated by gel f i l trat ion on a Sephadex G-200 column 
(2.28 X 93 cm). Similarly, aggregates of unconjugated IgG 
were also prepared . 
(b) Procedure 
In order to determine the binding of 
FITC-IgG (agg) to the GPBL. freshly isolated lymphocytes 
were suspended in assay buffer A (PBS pH 7.4, containing 
1% bovine serum albumin, 0.2% NaNa^' Three series of 
tubes were prepared each containing 10^ cel ls . In set A, 
cells were treated with increasing concentrations of 
FITC - IgG in buffer A and the final volume adjusted to 
1 ml. In set C', which served as a s t andard , duplicates 
of set A were prepared . The tubes were incubated for two 
hours with gentle shaking at 4°C. The cells from set 
A and B were centrifuged at 600g on Remi T8C for 10 
minutes and washed twice with cold (8°C) assay buffer. 
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These were then lysed by resuspending the cell pellet in 
2 ml of assay buffer containing 0.5% NP-40 solution. The 
tubes were again centrifuged for 10 minutes at 600g and 
the supernatant was taken for fluorescence measurements. 
Fluorescence was measured at 520 nm on Shimadzu RF-540 
spectrofluorophotometer keeping excitation wavelenght 
at 495 nm. 
(c) ' Data ana lys i s 
Fluorescence values of the 'non specific ' binding 
points (series B) were subtracted from the values of the 
experimental points (series A) to obtain the specific cell 
bound fluorescence. In order to convert the cell bound 
fluorescence into concentration of bound aggregate , a 
s tandard plot of fluorescence intensi ty versus total 
concentration of aggrega tes , in the presence of cell lysates 
(series C of the binding assay) was experimentally 
established (Fig. 11). 
f 
13. Interaction of cell surface IgG binding proteins with 
FITC-conjugated heat aggregated IgG: 
Binding of aggregated IgG to GPBL was studied 
spectrofluorophotometrically under different conditions of 
pH and ionic s t rength . 
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Fig . 11: Calibration curve for the estimation of 
FITC-conjugated IgG. The s t ra ight l ine was 
drawn by the method of least squares and fits 
the equation: 
Relative Fluorescence = 0.222 [ng.FITC-IgG] + 2.765. 
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(b) Effect of ionic strength 
The effect of ionic strength on the binding of 
FITC-conjugated immunoglobulins to lymphocytes was 
investigated in 10 mM sodium phosphate buffer pH 7.4, 
containing different concentrations of NaCl (0-0.8 M). The 
cells and l igand were exposed to desired ionic strength for 
two hours at 8°C and the binding determined spectrofluoro-
metrically as described ea r l i e r . 
(b) Effect of pH 
The binding of aggregated IgG to the lymphocytes 
was studied at different pH values in the pH range 6-9, 
which was maintained ei ther by 0.01 M sodium phosphate 
buffer (pH 6-8) or by 0-0.01 M sodium carbonate buffer 
(pH 9) . FITC-conjugated IgG was incubated with fixed 
number of cells at the desired pH for two hours at 8°C 
and the binding measured spectrofluorometrically. 
I I I . RESULTS AND DISCUSSION 
1. Iso lat ion of IgG b ind ing protein from goat lymphocytes: 
In the p r e s e n t s t u d y , IgG b i n d i n g p ro te in h a s 
been i so l a t ed by a f f in i ty c h r o m a t o g r a p h y from a mixed 
popu la t i on of goat l y m p h o c y t e s . I n c i d e n t a l l y , two 
immunoadsorben t s p r e p a r e d from e i t h e r immobil ized 
a n t i g e n - a n t i b o d y complex or h e a t a g g r e g a t e d immunoglobul in 
h a v e been used in the p a s t for the i so l a t i on of IgG 
b i n d i n g p r o t e i n . The l a t t e r a f f in i ty ge l was found to be 
more a d e q u a t e for the i s o l a t i o n of F c - r e c e p t o r in r e l a t i v e l y 
l a r g e r amounts ( T a k a c s , 1980). Acco rd ing ly , t he a f f in i ty 
gel used in these s t u d i e s was h e a t a g g r e g a t e d 
IgG-Sepharose 4B which w a s p r e p a r e d a s d e s c r i b e d in the 
' e x p e r i m e n t a l s e c t i o n ' . 
IgG b i n d i n g p r o t e i n was i s o l a t e d from lymphocy te 
membrane a s well a s from whole c e l l . The IgG b i n d i n g 
p ro te in i s o l a t e d by e i t h e r method was found to be i d e n t i c a l 
in i t s marked t e n d e n c y of u n d e r g o i n g a g g r e g a t i o n in 
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aqueous buffer and in specific interact ion with heterologous 
and homologous IgG i . e . human IgG and goat IgG. It 
should be pointed out that the two IgG preparat ions were 
obtained from fresh plasma by sal t fractionation, followed 
by chromatography on DEAE-cellulose and Sephadex G-200 
columns as reported ear l ie r from this laboratory (I rshad 
et a l . , 1981). 
(a) Isolation from whole cells 
The elution profile of IgG binding protein on heat 
aggregated IgG-Sepharose 4B column is shown in Fig. 12, 
The protein extracted from 5 x 10^ cells with the 
solubilizing buffer (10 mM PBS pH 7.4, containing 0.5% 
NP-40, 2 mM PMSF and 3 mM EDTA) was used for the 
isolation of IgG binding protein. About 57 mg of protein 
t 
was passed through the column and majority of the protein 
was found in the washings . The amount of protein bound 
to affinity column which was eluted with 0.5 M acetic acid 
containing 0.1% NP-40, was found to be about 800 \ig. 
Thus, from 50 million cells per ml, the amount of receptor 
isolated was less than one milligram. The receptor yield 
was estimated to be 1.4% of the NP-40 solubilized material 
applied to the column. However, the interest ing 
observation was that the receptor was active towards the affinity 
column as shown in Fig . 13, where it can be seen that the 
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Fig . 12: Affinity chromatography of protein solubilized 
from whole cells by NP-40 on aggregated 
IgG-Sepharose AB gel . '' 
About 77 mg. protein was incubated with 
15 ml of heat aggregated IgG-Sepharose 4B gel 
overnight . After packing the gel in syringe 
(1.4 X 10 cm), the unbound protein was washed 
with PBS containing 0.1% NP-40. The bound 
protein was eluted with 0.5 M acetic acid 
containing 0.1% NP-40 in 3 ml fractions. The 
column was monitored by modified Lowry's method 
(Cabib and Polacheck. 1984). 
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F ig . 13: Rebindlng of IgG binding protein 
affinity chromatography to 
IgG-Sepharose AB gel . 
About 0.2 mg. protein was applied on heat 
aggregated IgG-Sepharose 4B column(1.4 x 10 cm). 
After washing with PBS containing 0.1% NP-40, 
the bound protein was eluted with 0.5 M acetic 
acid containing 0.1% NP-40. The column was 
monitored, by modified Lowry's method (Cabib 
and Polacheck, 1984). 
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maximum elution took place at 9 ml of eluting buffer. 
Similar elution profile was obtained in Fig. 12. These 
resul ts suggested that the affinity purified receptor was 
fully functional. 
(b) Isolation from membrane 
Alternatively, the membrane fraction obtained 
from 5 X lO^ cells (see experimental section) was 
solubilized in 10 mM PBS pH 7.4, containing 0.5% NP-40, 
2 mM PMSF and 3 mM EDTA and loaded on heat aggregated 
IgG-Sepharose 4B column (1.4 % 10 cm). After the removal 
of nonspecifically bound protein by washing with chilled 
PBS containing 0.1% NP-40, the bound protein v/as eluted 
in the same way as described above. The elution profile 
is shown in Fig. 14. The protein elutifig from the affinity 
column was found to be 1.1% of the solubilized membrane 
material applied to the column. 
The overal l recovery of Fc receptor purified by 
different workers var ies from laboratory to laboratory 
which can be inherent to the different extraction and 
purification procedures. The difference in the protein yield 
isolated from this study and that reported by Takacs (1980) 
(0.5% - 0.8%) is due to the fact that crude membrane 
fraction was used in this study which can account for 
more nonspecific binding to the column. This increase in 
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Fig . 14: Affinity chromatography of NP-40 solubilized 
lymphocyte membrane on aggregated IgG-Sepharose 
4B ge l . 
About 2.8 mg. protein was incubated with 
15 ml of heat aggregated IgG-Sepharose AB gel 
overnight . After packing the gel in syringe 
(l.A X 10 cm), the unbound protein was washed 
with PBS containing 0,1% NP-40. The bound 
protein was eluted with 0.5 M acetic acid 
containing 0.1% NP-40 In 3 ml fract ions. The 
column was monitored by modified Lowry's method 
(Cabib and Polacheck, 1984). 
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nonspecific binding may also be a t t r ibuted to the washing 
eluent which contains only 0.1% NP-40, v/hereas in ear l ie r 
studies nonspecifically adsorbed material was removed by 
washing the column extensively with buffer containing 0.5% 
NP-40 (Takacs, 1980). I t is of in teres t to note tha t the 
receptor yield obtained in th is study (1.1%) was found to 
be similar to that (1%) found loy Vojtiskova and Franek 
(1984). Mikulsa et a l . (1982) have solubilized membrane 
with lithium diiodosalicylate and phenol and used this 
grude glycoprotein fraction for the isolation of Fcv'R by 
immunoprecipitation. They found that purified ^ c y R 
constitutes about 1.5 to 2% of the crude glycoprotein 
fraction. Thus, the yield of FcR obtained by 
immunoprecipitation is higher than that for affinity 
columns. 
2. Detection of IgG binding protein on lymphocyte surface: 
The presence of IgG binding protein on the 
surface of lymphocytes was detected by studying the 
binding of FITC-conjugate of aggregated IgG (agg FITC-IgG) 
to goat per ipheral blood lymphocytes. The binding of heat 
aggregated IgG to receptor on lymphocyte was studied by 
incubat ing 5 x 106 cells in the binding buffer (see legend 
to Fig. 15.) with increasing concentrations (2-10 ;ig/ml) of 
aggregated FITC-IgG at B^C for two hours . The 
F ITC - agg IgG added; pg 
Fig. 15: Detection of IgG binding protein on the surface of 
goat per iphera l blood lymphocytes by specific 
binding of fluorescein conjugated heat aggregated 
goat IgG. 
Aggregated FITC-IgG (2-10 jig) was 
Incubated at S'^ C for two hours with 4.76 x 10^ 
lymphocytes in PBS pH 7.4, containing 1% BSA 
and 0.2% NaN^- The bound protein was determined 
• • " 520 spectrofluorometrically at 
excitation wavelength at 495 
nm, keeping 
nm, 
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spectrofluorometric resul ts on the interaction of aggregated 
IgG-FITC conjugate with IgG receptors are shown in 
Fig . 15. It can be- seen in Fig . 15 that the binding of 
IgG increased subs tan t ia l ly with increase in IgG 
concentration upto 9 ug/ml beyond which a further 
increase in IgG concentration caused very l i t t le or no 
change in b ind ing . 
These resu l t s provide definite evidence for the 
presence of IgG binding protein on the surface of GPBL. 
Homologous aggregated IgG was used in these studies 
because the extent of i ts binding to cells is expected to be 
subs tant ia l ly h igher . The binding of heat aggregated IgG 
to cells was sa tu rab le , which is consistent with the 
specific nature of the binding of the IgG by cell surface 
receptors . The amount of aggregated IgG required to 
sa tura te the binding si te on cells was 0.191 pg/ml (Fig. 15) 
-12 
which is equivalent to about 1.27 x 10 moles of IgG 
monomer. This would mean tha t about 1.5 x 10 IgG 
monomer molecules were bound per cell . Assuming a 
stochiometery of IgG to receptor of 1 : 1, these resu l t s 
would indicate the presence of about 10^ moles of receptor 
on the cell surface, which is similar to that found for 
human leukemia receptor (10 -10^ receptors per cell) (Segal 
et a l . , 1979; Alexander et a l . , 1979), 
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We have assumed that each IgG monomer in 
aggregated IgG binds to the cell surface receptor under 
sa tura t ing conditions, which may not be t rue . Since an 
oligomer may be attached to the cell surface by only one 
or two IgG monomers, the rest of the IgG monomers may be 
redundant . Thus, the total number of receptor ' s per cell is 
l ikely to be subs tant ia l ly lower. 
3. Binding of immunoglobulin to intact lymphocytes: 
Binding of aggregated IgG to goat per iphera l 
blood lymphocytes was studied spectrofluorometrically under 
different experimental conditions of pH and ionic s t rength. 
(a) Effect of ionic strength 
The effect of ionic s t rength on the binding of 
heat aggregated FITC-IgG to lymphocytes was studied 
using different concentrations of NaCl (0-0.8 M) and the 
results are graphica l ly shown in Fig . 16. Maximum 
binding was observed at physiological ionic s t rength . 
Howiever, a g radua l decrease in the binding of IgG to 
receptor was seen on increasing NaCl concentration 
(0.2-0.8 M). For ra t intestine receptor, the degree of 
binding was independent of the buffer ion used 
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Fig . 16: Effect of ionic s trength on the interaction of IgG 
binding proteins on lymphocyte surface with 
immunoglobulins. 
Ten ng. of heat aggregated FITC-IgG was 
incubated with 10^ cells in 10 mM sodium 
phosphate buffer containing 1% BSA, 0.2% NaN 
and 0-0.8 M NaCl for two hours at 8°C. The 
bound protein was measured spectrofluorometrically 
at 520 nm, keeping excitation wavelength at 
495 nm. 
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e .g . Tris-HCl, phosphate or NaCl in combination of either 
of these (Wallace and Rees, 1980). However, maximum 
binding occured at a re la t ively low ionic strength with an 
optimum binding at 60 mM Tris-HCl buffer (Wallace and 
Rees, 1980). At low ionic s t rength , the binding of murine 
aggregated IgG2b to i t s receptor on human monocyte cell 
l ine U937 is enhanced, whereas the binding of monomeric 
Ig.G2a to i t s receptor is not affected (Jones et a l . , 1985). 
Restricted chemical modification of acidic side chains of 
FcR fragment abolished i t s binding to human neutrophil Fc 
receptor (Bradger et a l . , 1982). Polycations such as 
polylysine as well as polyanions like dextran sulphate 
inhibi t the binding of immune complexes to FcR (Fornusek 
and Vetvica, 1984). All these facts suggest that there 
exist important ionic interact ions between IgG and its 
receptor. 
(b) Effect of pH 
The effect of pH on the binding of heat 
aggregated FITC-IgG to cell surface receptors on 
lymphocytes was studied in the pH range 6-9 (using 10 mM 
sodium phosphate buffer for maintainiifg pH 6-8 and 10 mM 
sodium carbonate buffer for maintaining pH 9.0) at 4°C. 
The resul ts are graphica l ly shown in Fig. 17, where the 
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Fig . Effect of pH on fluorescence 
FITC-conjugated IgG(A) and i t s interaction with 
IgG binding proteins on lymphocyte surface(B). 
Ten pg. of heat aggregated FITC-IgG was 
incubated with 10^ cells in 10 mM sodium 
phosphate (pH 6-8) or 10 n»M sodium carbonate 
buffer (pH 9-10> for two hours at 8^C. Below pH 
6.0 sodium acetate (10 mM) buffer was employed. 
The bound protein was measured 
spectrofluorometrically at 520 nm, keeping 
excitation v/avelength at 495 nm. The upper 
curve represents the effect of pH on the re la t ive 
fluorescence of the l igand i . e . FITC-IgG. 
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upper curve depicts the pH dependence of the fluorescence 
of FITC-IgG. It can be seen in Fig. 17(A) that the 
fluorescence of FITC-IgG itself depends on pH, in the acid 
pH range . However, above pH 7.0, the fluorescence of the 
conjugated heat aggregated IgG becomes independent of pH. 
The pH dependence of the binding of IgG to cell surface 
receptor is shown in Fig. 17(B), where it can be seen that 
the pH var ia t ion above or below pH 7.0, caused 
s ignif icant decrease in fluorescence which can be at t r ibuted to 
the decrease in binding of IgG to cell surface receptor. However, 
such unequivocal in terpreta t ion for the decrease in 
fluorescence below pH 7.0 in terms of decrease in binding 
of IgG is not possible. Therefore, meaningful conclusion 
can be made on the bas is of our resul ts observed above 
pH . 7.0. Regardless of the discrepancy involved in the 
exact interpretat ion of low pH resu l t s , the resul ts 
presented in this disser ta t ion unambiguously demonstrate the 
role of polar interact ions in the binding of immunoglobulins 
to the cell surface receptor on goat lymphocytes. An 
attempt was made to compute the apparent pK value of the 
ionizable groups whose dissociation above pH 7.0 causes 
reduction in binding. The approximate pK value was 
computed to be close to pH 7 .5 . It is of interest to note 
that th is happens to be the most probable pK value of 
^ amino groups (Tanford, 196^tC * 5 T 4 ^ - p'ut^ti|ileft^ 
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group might have been contributed either by the Fc 
receptor or by the l i gand . The former is more likely in 
view of the modification of amino group of IgG during i ts 
conjugation with FITC. Evidence for the involvement of 
electrostatic interact ions has been made ava i lab le from our 
binding studies at different ionic strength which showed 
that an increase in ionic strength caused expected 
decrease in b ind ing . 
Although the IgG-receptor interact ion is known to 
depend on pH and ionic s t rength, observations made on 
different prepara t ions of the receptor are often conflicting. 
Thus, while the receptor from intes t ina l brush border 
membrane of neonatal r a t s was optimally active at pH 6.6 
and inactive at pH 7.4 (Wallace and Rees, 1980), that 
from mouse macrophage continued to show subs tan t ia l 
act ivi ty upto pH 9.0. The receptor activi ty was completely 
abolished at pH 10.0 (Mellman and Unkeless, 1980). 
Further chick yolk sac receptor is inact ivated at pH 8.0 
(Tressler and Roth, 1987). The loss of receptor act ivi ty 
that occured by exposure to a lkal ine pH was however 
reversible (Jackson et a l . , 1987). 
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